Published in Breast Cancer Res Treat on September 18, 2007
Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer (LALEAST) | NCT03917082
Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial. Lancet Oncol (2012) 3.03
Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review. Breast Cancer Res Treat (2012) 3.02
Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res (2008) 2.94
Breast cancer in young women and its impact on reproductive function. Hum Reprod Update (2009) 1.40
Relationship between deficits in overall quality of life and non-small-cell lung cancer survival. J Clin Oncol (2012) 1.33
Musculoskeletal adverse events associated with adjuvant aromatase inhibitors. J Oncol (2010) 1.08
Role of the general practitioner during the active breast cancer treatment phase: an analysis of health care use. Support Care Cancer (2011) 0.97
Acupuncture improves health-related quality-of-life (HRQoL) and sleep in women with breast cancer and hot flushes. Support Care Cancer (2011) 0.96
Better exercise adherence after treatment for cancer (BEAT Cancer) study: rationale, design, and methods. Contemp Clin Trials (2011) 0.94
Trends in co-prescribing of antidepressants and tamoxifen among women with breast cancer, 2004-2010. Breast Cancer Res Treat (2012) 0.92
Long-term assessment of quality of life in the Intergroup Exemestane Study: 5 years post-randomisation. Br J Cancer (2012) 0.92
Breast cancer medications and vision: effects of treatments for early-stage disease. Curr Eye Res (2011) 0.86
Lifestyle Factors in Cancer Survivorship: Where We Are and Where We Are Headed. J Pers Med (2015) 0.86
Exercise in clinical cancer care: a call to action and program development description. Curr Oncol (2012) 0.84
Contemporary quality of life issues affecting gynecologic cancer survivors. Hematol Oncol Clin North Am (2011) 0.84
Self-efficacy for coping with symptoms moderates the relationship between physical symptoms and well-being in breast cancer survivors taking adjuvant endocrine therapy. Support Care Cancer (2014) 0.83
Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort. Cancer (2013) 0.82
Breast cancer survivorship issues. Hematol Oncol Clin North Am (2013) 0.82
Long-term psychological benefits of cognitive-behavioral stress management for women with breast cancer: 11-year follow-up of a randomized controlled trial. Cancer (2015) 0.81
Nonhormonal management of hot flashes for women on risk reduction therapy. J Natl Compr Canc Netw (2010) 0.81
The impact of age on changes in quality of life among breast cancer survivors treated with breast-conserving surgery and radiotherapy. Br J Cancer (2015) 0.80
Optimizing expectations to prevent side effects and enhance quality of life in breast cancer patients undergoing endocrine therapy: study protocol of a randomized controlled trial. BMC Cancer (2013) 0.80
A review of the use of exemestane in early breast cancer. Ther Clin Risk Manag (2009) 0.80
Early discontinuation of adjuvant hormone therapy is associated with a poor prognosis in Japanese breast cancer patients. Surg Today (2013) 0.79
Adjuvant therapy use among Appalachian breast cancer survivors. Medicine (Baltimore) (2015) 0.79
Association Between Out-Of-Pocket Costs, Race/Ethnicity, and Adjuvant Endocrine Therapy Adherence Among Medicare Patients With Breast Cancer. J Clin Oncol (2016) 0.79
Atrophic vaginitis in breast cancer survivors: a difficult survivorship issue. J Pers Med (2015) 0.78
Effect of Expressive Writing Intervention on Health Outcomes in Breast Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PLoS One (2015) 0.78
Hot flashes: the ongoing search for effective interventions. Menopause (2012) 0.78
Sexual function in breast cancer patients: a prospective study from Iran. J Exp Clin Cancer Res (2012) 0.78
Symptoms and Symptom Attribution Among Women on Endocrine Therapy for Breast Cancer. Oncologist (2015) 0.77
Geographic disparities in adherence to adjuvant endocrine therapy in Appalachian women with breast cancer. Res Social Adm Pharm (2016) 0.77
Provider perspectives on patient-provider communication for adjuvant endocrine therapy symptom management. Support Care Cancer (2016) 0.76
Oncology providers' perspectives on endocrine therapy prescribing and management. Patient Prefer Adherence (2016) 0.76
A self-report instrument that describes urogenital atrophy symptoms in breast cancer survivors. West J Nurs Res (2010) 0.76
Antihormonal treatment associated musculoskeletal pain in women with breast cancer in the adjuvant setting. Onco Targets Ther (2016) 0.75
Vaginal Estrogen Therapy for Patients with Breast Cancer. Geburtshilfe Frauenheilkd (2013) 0.75
Behavioral Interventions to Enhance Adherence to Hormone Therapy in Breast Cancer Survivors: A Systematic Literature Review. Clin Breast Cancer (2016) 0.75
Physical Activity and Breast Cancer: A Qualitative Study on the Barriers to and Facilitators of Exercise Promotion from the Perspective of Health Care Professionals. Physiother Can (2016) 0.75
Menopausal symptoms in breast cancer survivors: management update. Br J Gen Pract (2013) 0.75
A pilot study of website information regarding aromatase inhibitors: dietary supplement interactions. J Altern Complement Med (2011) 0.75
Validity and reliability of the Patient-Reported Arthralgia Inventory: validation of a newly-developed survey instrument to measure arthralgia. Patient Relat Outcome Meas (2015) 0.75
Racial differences in adjuvant endocrine therapy use and discontinuation in association with mortality among Medicare breast cancer patients by receptor status. Cancer Epidemiol Biomarkers Prev (2017) 0.75
Factors related to the experience of menopausal symptoms in women prescribed tamoxifen. J Psychosom Obstet Gynaecol (2016) 0.75
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med (2004) 10.41
Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat (2005) 3.23
International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy. J Natl Cancer Inst (2009) 2.77
Effects of anastrozole on cognitive performance in postmenopausal women: a randomised, double-blind chemoprevention trial (IBIS II). Lancet Oncol (2008) 2.01
Rasch fit statistics and sample size considerations for polytomous data. BMC Med Res Methodol (2008) 1.77
What oncologists believe they said and what patients believe they heard: an analysis of phase I trial discussions. J Clin Oncol (2010) 1.41
Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid. Support Care Cancer (2013) 1.12
A Rasch and confirmatory factor analysis of the general health questionnaire (GHQ)--12. Health Qual Life Outcomes (2010) 1.02
Fallowfield's Sexual Activity Questionnaire in women with without and at risk of cancer. Menopause Int (2007) 0.99
Communication and informed consent in phase 1 trials: a review of the literature from January 2005 to July 2009. Support Care Cancer (2010) 0.92
Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer. Radiother Oncol (2004) 0.91
Randomized controlled trial of pulmonary metastasectomy in colorectal cancer: PulMiCC International is open in Italy. Oncologist (2013) 0.91
Adjuvant chemotherapy in elderly women with breast cancer: patients' perspectives on information giving and decision making. Psychooncology (2013) 0.85
Anastrozole and letrozole: an investigation and comparison of quality of life and tolerability. Breast Cancer Res Treat (2010) 0.82
Patient-reported outcome instruments used to assess pain and functioning in studies of bisphosphonate treatment for bone metastases. Support Care Cancer (2012) 0.81
The views of patients and the general public about expensive anti-cancer drugs in the NHS: a questionnaire-based study. JRSM Short Rep (2011) 0.80
A UK-wide survey of follow-up practices for patients with high-grade glioma treated with radical intent. J Eval Clin Pract (2010) 0.78
After going through chemotherapy I can't see another needle. Eur J Oncol Nurs (2006) 0.78
Intravenous versus Subcutaneous Drug Administration. Which Do Patients Prefer? A Systematic Review. Patient (2014) 0.76
Breast cancer screening review. What should women do in the meantime? BMJ (2011) 0.75